ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 2610 • ACR Convergence 2025

    Imaging remission in aortitis associated with giant cell arteritis. Multicenter study with tocilizumab in monotherapy and combined therapy

    Adrian Martin-Gutierrez1, Javier Loricera2, Diana Prieto-Peña3, Vicente Aldasoro Cáceres4, Olga Maiz5, Eugenio de Miguel6, Eva Galíndez Agirregoikoa7, Ivan Ferraz Amaro8, Santos Castañeda9 and Ricardo Blanco10, 1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Renedo de Piélagos, Spain, 2Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 3Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Santander, Spain, 4Hospital Universitario de Navarra, Pamplona, Spain, 5Hospital Universitario de Donosti, Donostia, Spain, 6Hospital Universitario La Paz, Madrid, Spain, 7BASURTO UNIVERSITY HOSPITAL, BILBAO, Spain, 8Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 9Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Madrid, Spain, 10Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain

    Background/Purpose: Aortitis is a frequent and potential severe complication of giant cell arteritis (GCA)(GCA-aortitis). Tocilizumab (TCZ) was approved for the treatment of GCA, but its…
  • Abstract Number: 1969 • ACR Convergence 2025

    Enhancing Objective Evaluation of Raynaud’s in Veterans with Scleroderma-related Hand Pain: Integrating Patient Reported Outcomes and Nailfold Capillaroscopy

    Genessis Maldonado1, Sowmika Rao1 and Tracy Frech2, 1Vanderbilt University Medical Center, Nashville, 2Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Raynaud’s phenomenon (RP) is a painful and disabling feature of systemic sclerosis (SSc) that significantly impairs quality of life. Tools that integrate subjective symptom…
  • Abstract Number: 1946 • ACR Convergence 2025

    Quantitative Imaging Analysis of Chest Computed Tomography in Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Emily Anthone1, Emily Wan2, Aimee Schreiner1, Katherine Wysham3, Gary Kunkel4, Grant Cannon5, Andreas Reimold6, John Richards7, Dana Ascherman8, Gail Kerr9, Paul Monach10, Halie Frideres11, Punyasha Roul12, Scott Matson13, Joshua Baker14, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2VA Boston, Omaha, NE, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 5University of Utah and Salt Lake City VA, Salt Lake City, UT, 6Dallas VA Medical Center, Dallas, TX, 7Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 8University of Pittsburgh, Pittsburgh, PA, 9Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 10VA Boston Healthcare System, Boston, MA, 11UNMC Department of Rheumatology, Omaha, NE, 12UNMC, Omaha, NE, 13University of Kansas, Kansas City, MO, 14University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Interstitial lung disease (ILD) frequently complicates the disease course in RA. While forced vital capacity (FVC) from pulmonary function tests (PFTs) is the most…
  • Abstract Number: 1631 • ACR Convergence 2025

    New Arterial Damage in Takayasu’s Arteritis

    Tanaz Kermani1, Sema Kaymaz-Tahra2, Aysegul Avcu3, Fatma Alibaz-Oner4, Haner Direskeneli3 and Peter Merkel5, 1University of California Los Angeles, Santa Monica, CA, 2Bahcesehir University Faculty of Medicine Department of Internal Medicine Division of Rheumatology, Istanbul, Turkey, 3Marmara University, Istanbul, Turkey, 4MARMARA UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DIVISION OF RHEUMATOLOGY, Istanbul, Turkey, 5University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Damage is one of the consequences of disease and is often considered irreversible. This study aimed to evaluate new arterial damage in Takayasu’s arteritis…
  • Abstract Number: 1173 • ACR Convergence 2025

    Prevalence of Coronary Artery Involvement in IgG4-Related Disease Detected by Non-Gated Cross-Sectional Imaging

    Matthew Charles Baker1, Lauren Taylor2, Haziq Siddiqi2, Jison Hong2 and Brian Pogatchnik2, 1Stanford University, Menlo Park, CA, 2Stanford University, Stanford, CA

    Background/Purpose: IgG4-related disease (IgG4-RD) classically presents with a mass or diffusely enlarged organ, but it also affects blood vessels of all sizes. Coronary artery involvement…
  • Abstract Number: 0740 • ACR Convergence 2025

    Intravenous versus subcutaneous administration of Tocilizumab in aortitis associated with giant cell arteritis: multicenter open-label study of 196 patients

    Carmen Secada-Gómez1, Javier Loricera2, Adrian Martin-Gutierrez3, Santos Castañeda4 and Ricardo Blanco1, 1Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 2Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 3Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Renedo de Piélagos, Spain, 4Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Madrid, Spain

    Background/Purpose: Aortitis associated to Giant cell arteritis (GCA) (GCA-aortitis) is one of the most severe manifestation of GCA. Tocilizumab (TCZ) has demonstrated efficacy in large-vessel…
  • Abstract Number: 0092 • ACR Convergence 2025

    SynovAI: A Revolutionary AI Framework for Enhanced Detection and Differentiation of Rheumatoid Arthritis, Osteoarthritis, and Spondyloarthritis via Advanced Ultrasound Imaging

    Mojtaba S. Fazli1, Mariani Diaz Deluna2, Suzanne Tamang2 and Robert Fairchild2, 1Stanford University, San Francisco, CA, 2Stanford University, Stanford, CA

    Background/Purpose: Rheumatology musculoskeletal ultrasound (MSKUS) is a powerful technique to identify and differentiate arthritidies joint pathology, yet MSKUS is highly dependent on user experience. Techniques…
  • Abstract Number: 2562 • ACR Convergence 2025

    Enhancing Hand Osteoarthritis Classification with Generative AI: A CycleGAN and EfficientNetB7 Approach

    Zhen Cao1, Juan Shan2, Xiaohan Jiang1, Qiong Wang1, Timothy McAlington3, Jeffrey Driban4 and Ming Zhang5, 1Boston University, Boston, MA, 2Pace University, New York, NY, 3UMass Chan School of Medicine, Arlington, MA, 4University of Massachusetts Chan Medical School, Marlborough, NH, 5Boston University, Westford, MA

    Background/Purpose: Hand osteoarthritis (OA) is a prevalent disease that significantly impacts hand function and quality of life. The Kellgren-Lawrence (KL) grading system is widely used…
  • Abstract Number: 1968 • ACR Convergence 2025

    Relationship between ultrasonographic and elastographic findings of the median nerve and disease activity and hand function in patients with rheumatoid arthritis

    Gulperi ISAZADE KASIMZADE1, Ismihan Sunar2, Sebnem ATAMAN3 and Aysun GENC1, 1Ankara University School of Medicine, Physical Medicine and Rehabilitation, Ankara, Turkey, 2Ankara University School of Medicine, Physical Medicine and Rehabilitation, Rheumatology, Ankara, Turkey, 3Ankara University School of Medicine, Rheumatology, Turkey, Ankara, Turkey

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune joint disease with systemic involvement which can affect the nerves through either compressive pathology due to intra-articular synovitis…
  • Abstract Number: 1945 • ACR Convergence 2025

    Significance of Finger Joint Tenderness With or Without Swelling in Relation to MRI, Ultrasound, and X-Ray Findings in Psoriatic Arthritis_Final results

    Victoria Furer1, iris Eshed2, Moshe Iluz1, Ori Elkayam3 and Ari Polachek4, 1Tel-Aviv Medical Center, Tel-Aviv, Israel, 2Department of Diagnostic Imaging, Sheba Medical Center, Tel Hashomer affiliated with School of Medicine, Tel Aviv University, Tel Aviv, Israel, 3Tel Aviv medical center, Tel Aviv, Israel, 4Rheumatology Institute of Beilinson Hospital, Petah Tikva, Israel

    Background/Purpose: Musculoskeletal involvement in psoriatic arthritis (PsA) affects both articular and extra-articular structures, presenting as inflammatory and structural lesions. The relationship between tender and/or swollen…
  • Abstract Number: 1620 • ACR Convergence 2025

    Correlation Between Histopathological Findings and PET-CT Results in Patients With Inflammatory Aortitis

    Guillem Verdaguer Faja1, rafeal Benito-Melero2, Ignasi Espadaler Fabregó1, Laura López Vilaró1, Mónica Velasco Nuño1, Antonio José Barros Membrilla1, Susana Fernández Sánchez3, Jaime-Félix Dilmé Muñóz1, Ivan Castellvi4, Berta Magallares5, Hye Sang Park1, Asier García-Alija6, Albert Casals Urquiza3, Ana Laiz3, Cesar Diaz-Torne1, Jose Luis Tandaipan7, Luis Sainz Comas1, Helena Codes Mendez3, Júlia Bernardez Moreno8, Carla Marco-Pascual1, Concepción Pitarch3, Andrea Garcia3, Núria Fernández3, Lorena Úbeda3 and Hector Corominas8, 1Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2MD, barcelona, Spain, 3Sant Pau Hospital, Barcelona, Spain, 4Hospital Universitari de la Santa Creu i Sant Pau, Sant Just Desvern, Spain, 5Hospital de Sant Pau, Bareclona, 6Sant Pau Hospital, Barcelona, Catalonia, Spain, 7Hospital de la Santa Creu i Sant Pau, Terrassa, Spain, 8Hospital de Sant Pau, Barcelona, Spain

    Background/Purpose: Inflammatory aortitis is an uncommon condition that can be associated with rheumatologic, neoplastic, or infectious diseases. GCA and isolated aortitis are the most common…
  • Abstract Number: 1172 • ACR Convergence 2025

    A Phase II, Single-Site, Open-Label Study of Zanubrutinib in Patients with IgG4-Related Disease

    Matthew Charles Baker1, Audra Horomanski2, Robert Fairchild3, Yuhan Liu3, Mariani Diaz Deluna3, Tobias Lanz4, Saurabh Gawde3, Mehdi Khalighi3, Benjamin Franc3, Mrudula Penta3, Nancy Pham3 and Kip Guja3, 1Stanford University, Menlo Park, CA, 2Stanford University, Palo Alto, CA, 3Stanford University, Stanford, CA, 4Stanford University, Stanford

    Background/Purpose: IgG4-related disease (IgG4-RD) is a chronic, systemic, immune-mediated disease that is commonly treated with B cell depletion. However, due to potential risks associated with…
  • Abstract Number: 0539 • ACR Convergence 2025

    Which instrument measuring structural damage progression in axial SpA is most sensitive to change? Analyses from the SPondyloArthritis Caught Early cohort

    Liese de Bruin1, Floris A. van Gaalen1, Manouk de Hooge2, Miranda van Lunteren1, Mary Lucy Marques3, Monique Reijnierse4, Roberta Ramonda5, Inger Jorid Berg6, Sofia Exarchou7, Robert Landewé8, Désirée Van Der Heijde1 and Sofia Ramiro9, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; and Coimbra Local Health Unit, Coimbra, Portugal, 4Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology Unit-DIMED-University of Padova ITALY, Padova, Padua, Italy, 66Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Nepal, 7Lund University, Åkarp, Skane Lan, Sweden, 8Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands; and Zuyderland Medical Center, Heerlen, Netherlands, 9Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: The assessment of structural damage progression is an important part of outcome assessment in axial SpA (axSpA). In order to test whether interventions can…
  • Abstract Number: 2470 • ACR Convergence 2025

    Impaired Myocardial Flow Reserve on 82-Rubidium Positron Emission Tomography in Patients with Systemic Sclerosis

    Attila Feher1, Morgan Emokpae2, Bindu Koyi2, Ibolya Csecs2, Baran Gunes3, Albert Sinusas2 and Monique Hinchcliff4, 1Yale University School of Medicine - New Haven, CT, New Haven, CT, 2Yale School of Medicine, New Haven, 3Yale University School of Medicine, Pompton Plains, NJ, 4Yale School of Medicine, Westport, CT

    Background/Purpose: Cardiovascular death ranks as the second leading cause of mortality related to systemic sclerosis (SSc), with coronary microvascular dysfunction (CMVD) likely contributing to this…
  • Abstract Number: 1967 • ACR Convergence 2025

    Developing an Algorithm to Quantify Dermatomyositis-Associated Calcinosis Using Infrared Imaging

    Saahil Sachdeva1, Briana Cervantes2, Lisa Rider3 and Adam Schiffenbauer4, 1NIEHS/NIBIB/NIH, Danville, CA, 2Department of Emergency Medicine, Norfolk, VA, 3National Institute of Environmental Health Sciences/National Institutes of Health, Environmental Autoimmunity Group, Bethesda, MD, 4National Institute of Health/National Institute of Dental and Craniofacial Research, Bethesda, MD

    Background/Purpose: Dermatomyositis (DM) is a rare autoimmune disease characterized by chronic muscle and skin inflammation. One potential complication of DM is calcinosis, the heterotopic calcification…
  • 1
  • 2
  • 3
  • …
  • 43
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology